Lack of Evidence for an Association between IL-17F Rs763780 Polymorphism and Pulmonary Tuberculosis

Immunol Invest. 2021 Aug;50(6):726-734. doi: 10.1080/08820139.2020.1787437. Epub 2020 Jul 7.

Abstract

The relationship between the interleukin-17F (IL-17F) rs763780 polymorphism and tuberculosis (TB) has been a source of debate. The potential association between the IL-17F rs763780 polymorphism and TB was investigated using a meta-analysis of case-control studies, which were obtained using the EMBASE, PubMed, CNKI, Scopus, and Web of Science databases. Heterogeneity across studies was evaluated, and summary odds ratios and 95% confidence intervals were computed to estimate a summary effect size using either a fixed-effects or random-effects model. Eight eligible studies comprising nine comparisons for the IL-17F rs763780 polymorphism (3824 cases and 3787 controls) were obtained for this meta-analysis. Although a significant relationship between IL-17F rs763780 and TB susceptibility was observed using the allele genetic model (odds ratio = 1.34, 95% confidence interval = 1.04-1.74), there was high heterogeneity among the studies (I2 = 79%, P=0.0001). The stratified analyses by race, type of tuberculosis, and Hardy-Weinberg equilibrium suggested that the IL-17F rs763780 polymorphism was not associated with risk of pulmonary tuberculosis and the heterogeneity disappeared. Hardy-Weinberg equilibrium is the main cause of the heterogeneity. No evidence was found through this meta-analysis that suggested an association between the IL-17F rs763780 polymorphism and risk of pulmonary tuberculosis.

Keywords: IL-17F; meta-analysis; polymorphism; rs763780; tuberculosis.

Publication types

  • Meta-Analysis

MeSH terms

  • Case-Control Studies
  • Gene Frequency
  • Genetic Predisposition to Disease*
  • Humans
  • Interleukin-17 / genetics*
  • Polymorphism, Single Nucleotide
  • Tuberculosis, Pulmonary / epidemiology
  • Tuberculosis, Pulmonary / genetics*

Substances

  • IL17F protein, human
  • Interleukin-17